Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06436690 · ClinicalTrials.gov registry record · NA
Optimizing Antibiotics Prescription
A NA study of Antimicrobial Resistance, sponsored by Penn State University.
- Active
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 2
- Study locations
NCT06436690 is a NA study of Antimicrobial Resistance that is active but no longer recruiting, run by Penn State University. The registered enrollment target is 56 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06436690, a NA study of Antimicrobial Resistance, is active but no longer recruiting, sponsored by Penn State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 2
- Study locations
Study Summary
Interventions that are low-cost, do not add substantially to the physician workload, are consistent with good physician practices and WHO guidelines, and serve as a reminder on the risks of overprescribing antibiotics are critically needed. The overall goal of the proposed project is to test the effect of two behavioral interventions targeted to junior physicians-specifically, requiring them to specify the diagnosis in the prescription note and providing feedback-on their antibiotics prescription rate; examine the intervention's effects across gender and caste; and draw lessons for scaling up the intervention.
Conditions Studied
Interventions
- BEHAVIORAL Individualized Feedback
- BEHAVIORAL Diagnosis Mandate
Study Locations (2)
Pennsylvania
- Pennsylvania State University - University Park
Bagmati
- Institute for Social and Environmental Research - Nepal - Bharatpur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2025-04-15 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06436690
The ClinicalTrials.gov registry entry for NCT06436690 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Antimicrobial Resistance appearing as the primary indexed condition, and to 2 interventions - of which Individualized Feedback is the first listed.
NCT06436690 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Bagmati.
Frequently Asked Questions
What is clinical trial NCT06436690 about?
NCT06436690 is a clinical study titled "Optimizing Antibiotics Prescription". Interventions that are low-cost, do not add substantially to the physician workload, are consistent with good physician practices and WHO guidelines, and serve as a reminder on the risks of overprescribing antibiotics are critically needed. The overall goal of the proposed project is to test the eff...
What is the current status of trial NCT06436690?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2025-04-15. Estimated completion is 2026-04-30.
What conditions does trial NCT06436690 study?
This clinical trial studies the following conditions: Antimicrobial Resistance.
What interventions are being tested in trial NCT06436690?
The interventions under investigation include: Individualized Feedback (BEHAVIORAL), Diagnosis Mandate (BEHAVIORAL).
Who is sponsoring clinical trial NCT06436690?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06436690 being conducted?
This trial has 2 study locations across Pennsylvania, Bagmati. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Antimicrobial Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.